Stifel Financial Corp Gritstone Bio, Inc. Transaction History

Stifel Financial Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.96 - $2.9 $482 - $713	-246 Reduced 0.8%	30,694 $78,000
Q4 2023 Feb 12, 2024	SELL	$1.28 - $2.85 $49,268 - $109,699	-38,491 Reduced 55.44%	30,940 $63,000
Q3 2023 Nov 13, 2023	SELL	$1.19 - $2.26 $257 - $488	-216 Reduced 0.31%	69,431 $119,000
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.03 $584 - $1,066	-352 Reduced 0.5%	69,647 $135,000
Q1 2023 May 12, 2023	BUY	$2.13 - $3.74 $2,696 - $4,734	1,266 Added 1.84%	69,999 $194,000
Q4 2022 Feb 13, 2023	SELL	$2.17 - $3.92 $2,721 - $4,915	-1,254 Reduced 1.79%	68,733 $237,000
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $25,869 - $49,951	10,516 Added 17.68%	69,987 $180,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $4,702 - $11,531	-2,657 Reduced 4.28%	59,471 $144,000
Q1 2022 May 13, 2022	SELL	$4.03 - $12.19 $9,470 - $28,646	-2,350 Reduced 3.64%	62,128 $256,000
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $156,015 - $244,175	-17,810 Reduced 21.64%	64,478 $829,000
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $112,104 - $236,801	17,489 Added 26.99%	82,288 $889,000
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $231,705 - $290,700	28,500 Added 78.51%	64,799 $592,000
Q1 2021 May 14, 2021	BUY	$4.07 - $27.11 $147,736 - $984,065	36,299 New	36,299 $342,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.